Luteinizing Hormone Variability in Polycystic Ovary Syndrome: A Comparative Analysis

An endocrine with metabolic condition known as Polycystic Ovarian Syndrome (PCOS) affects women who are of reproductive age, women with PCOS are a condition often associated with dysregulation of the hypothalamic-pituitary axis. A Cross-sectional study, the study included 88 patients who visited the outpatient clinic in total. These individuals were split up into two groups. All females are assessed the status of obesity by the body mass index (BMI), BMI= weight (kg) / height (m)², LH, FSH, Estradiol and Testosterone levels measured by ELISA technique. There was no discernible variation in BMI between groups A and B. (P ≥ 0.456), The patients' mean FSH and LH values were 5.06 mIU/ml and 5.47 mIU/ml, compared with group B mean that equal to 6.05 mlU/ml, 18.91mlU/ml respectively. Serum testosterone was slightly elevated in group B that was (41.19 ± 5.16 ng/dL), and (39.53 ± 4.98 ng/dL) in group A. Moreover, the level of estradiol (E2) in group A was 79.45ng/dL while in group B the level was 72.65 ng/dL there are no significant difference between two groups. The study found conflicting evidence regarding the impact of high LH levels on oocyte quality, fertilization, and pregnancy outcomes in PCOS patients. According to the research, ovarian theca cells from PCOS patients may be more effective than normal theca cells at converting androgenic precursors to testosterone. While ovulatory dysfunction in PCOS is linked to reduced estradiol production, the study indicates that ovarian tissue may still contribute to circulating estradiol levels in affected women.